Summary
Work History
Education
Skills
Languages
Affiliations
Work Availability
Timeline
Professional And Leadership Training
Volunteer Activities And Other Honors And Awards
Area Of Expertise
publication
Professional And Leadership Training
Volunteer Activities And Other Honors And Awards
Area Of Expertise
publication
Overview

Jalil Hakimi PM MBA

Richmond Hill,ON
There is a powerful driving force inside every human being that, once unleashed, can make any vision, dream, or desire a reality.
Tony Robbins

Summary

A seasoned Professional Life Science Leader with extensive experience in Diagnostic, Biopharmaceutical, and Academic Research and Development with a proven track record of achievements with 20 years of experience collaborating with teams to build seamless and cost-effective products. Excellent interpersonal and organizational skills. Experienced with assessing market competition by comparing the company's product to competitor's products.

Work History

Global Product Manager

Sartorius Stedim Biotech
03.2022 - Current
  • Oversaw global product development and partner relationships, enabling footprint expansion into new markets.
  • Communicated effectively with team members to deliver updates on project milestones and deadlines.
  • Documented user stories, specifications, and product features into detailed work order to communicate across teams and build mandatory requirements.
  • Developed product documentation to communicate upcoming features and products to internal teams.
  • Thrived in fast-paced, highly-adept team to develop and prioritize product features and build product roadmap.
  • Collaborated with sales, marketing, and support teams to launch products on time and within budget.
  • Maintained positive vendor relations to build strong partnerships.
  • Prioritized roadmap in order to achieve product goals and metrics.
  • Managed product demonstrations and testimonials for performance evaluation.
  • Reviewed new opportunities to drive business strategy at planning sessions.
  • Spearheaded collaborative efforts to bring products to market.
  • Liaised with clients to better understand business needs and the current market landscape.
  • Established, initiated and optimized business development strategies based on company targets, product specifications, market data, and budget factors.
  • Executed comprehensive marketing plans that consistently achieved targets for increased revenue.
  • Wrote and distributed press releases to increase brand visibility.
  • Analyzed and reported on KPIs to validate and demonstrate success of marketing campaigns.
  • Captured new customers by optimizing business strategies and launching products to diversify offerings.
  • Monitored market trends and competitor performance to update promotional strategies.
  • Compiled product and customer data to generate informed profit projections.
  • Conducted market research to identify new opportunities and target markets.

R&D Associate/Cellular and Immunochemical Assay Development and Vaccine Stability Expert

Sanofi Pasteur Canada
04.2001 - 03.2022
  • Played key roles in multiple projects from discovery to development of new vaccines
  • Successfully conducted numerous stability studies for multiple new human vaccine candidates, assessing formulation efficacy by biological assays
  • Established an in-vitro Peptide Specific T cell line generation based on Peptide, adeno virial or mRNA induced, DC generation, CD40L activated B cell lines, analyzed by SDSPAGE, Western blot, ELlSPOT, FACS and Caspase Assay methods
  • Master Trainer for designing, planning, and troubleshooting Generation of antigen specific T cell lines and multiple Stability Protocols
  • Procurement for Formulation and stability platform
  • Facilitator, BRD-Scientific Journal Club 2011-2015
  • Active Member of Sanofi Pasteur Joint Health and safety team 2002-2012.

Director Business Development-part-time

Qualinical Clinical Consulting Services
04.2018 - 12.2020
  • National & International Business Development and strategic planner for multidisciplinary medical diagnostic projects
  • Developing Business for Life, bringing new strategic plans, improving client relations, new product launch, market analysis, national and international clinical projects.

Manager Business Development-part-time

Fenton Technologies, Cardiac Experts
03.2016 - 03.2018
  • International Business Development multi-disciplinary medical projects
  • Developing Business Development and marketing strategy, improving client relations, new product launch, market analysis, leveraging business opportunities in Canada, USA and Middle East.

Manager Business Development-part-time

StarMedical Equipment, An Ultrasound Company
04.2013 - 09.2015
  • Empowered Business Development opportunities, sales marketing strategy, provided product shows, attended conferences, and delivered professional product presentations to major hospitals in GTA, improving client relations, successful marketing and product launch in Alberta, Halifax, leveraged international business opportunities Europe and Middle East.

Facility Manager(part-time)

Sunnybrook Research Institute
10.2003 - 05.2015
  • Successfully established and managed SRI Core Genotyping Facility
  • Established a Biobank Center for Prostate Cancer Project (SRI) including writing SOP to process DNA extraction and Plasma separation from whole blood
  • Provided genotyping services such as PCR based technical troubleshooting and setting up new molecular testing for Genome Canada and several prestigious research laboratories affiliated with University of Toronto and Mc Master University
  • Delivered excellent customer service, increased customer satisfaction, and relations with multiple laboratories, developed new test and modified and improved cumbersome test
  • Nurtured excellent client relations through on-time project delivery enhanced productivity, improved accuracy, reduced costs, enhanced efficiency, saved tremendous time, and successfully managed the facility for more than 11 years in charge of all technical, scientific, and financial responsibilities.

Genotyping Facility Manager, Immunology Department, University of Toronto

Ontario Cancer Institute (UHN)
01.2000 - 04.2001
  • Established a genotyping core facility center for MRC Research group; shared by three different research institutions; OCI, Mount Sinai Hospital Research Institute, U of T Medical Sciences Departments
  • Established excellent relationship among several stakeholders recognized by VP of OCI Research Dep
  • For excellent quality control service providing in a challenging time for animal facility, resulted in tremendous amount of cost saving and enhanced profitability of the department.

Senior Research Associate

Women's College Research Institute
07.1997 - 01.2000
  • Successfully developed DNA purification techniques from 30 years old pathological archival slides, acknowledged as significant contributor of achieving over half million dollars grant from Israel for the study of BRCA1 and BRCA2 mutations
  • Co-inventor of a unique Multiplex PCR test for detecting three common Ashkenazi Jewish BRCA1 and BRCA2 mutations
  • Technical Expertise: PCR, RT-PCR, DNA and RNA Purification, Protein Truncation Test, Molecular Assay Development for screening BRAC1 and BRCA2 genes.

Supervisor/Chief Technologist/Expert Biochemical and Immunochemical Diagnostic Assay Development

Pathobiology Laboratory Center
07.1989 - 03.1997
  • Supervised Clinical Immunology Department (7 technical staff)
  • Established 12 new clinical diagnostic assays for the first time in Iran
  • Developed various diagnostic assays using techniques such as ELISA, Fluorescent Microscopy, Electrophoresis, and Immunopathology.

Education

Executive Master of Business Administration (EMBA) -

Ivey Business School University of Western Ontario
07.2021

Project Management full Certificate -

University of Toronto
01.2011

Medical Laboratory Sciences BSc. (Major in Immunology) Undergraduate -

Babol (Mazandaran) Medical Sciences University, Iran
01.1998

Skills

  • Product Development: Enhance and launch biotech products
  • Market Analysis: Assess biotech trends and identify growth opportunities
  • Strategic Planning: Develop and execute growth strategies
  • Sales and Revenue Growth: Drive sales and revenue expansion
  • Regulatory Compliance: Ensure adherence to industry regulations
  • Risk Management: Identify and mitigate business risks
  • Networking: Build and maintain a strong industry network
  • Ethical Conduct: Uphold ethical standards in all activities
  • Business Planning
  • New Product Introductions
  • Tactical Support
  • Key Performance Indicators (KPI)
  • Project Management
  • Critical Thinking
  • Business Development
  • Staff Management
  • Organizational Leadership
  • Marketing Strategies and Research
  • Roadmap Development
  • Operational Efficiency
  • Technical Support
  • Industry Networking
  • Lean Methodology
  • Effective Organization
  • Strategic Vision
  • Promotional Events

Languages

English
Full Professional
Persian
Native or Bilingual
Turkish
Limited Working

Affiliations

International Society Cell and Gene Therapy

Advanced Therapy Phaciliate

International Society Stem Cell Research

American Society of Cancer Research



Work Availability

monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse

Timeline

Global Product Manager - Sartorius Stedim Biotech
03.2022 - Current
Director Business Development-part-time - Qualinical Clinical Consulting Services
04.2018 - 12.2020
Manager Business Development-part-time - Fenton Technologies, Cardiac Experts
03.2016 - 03.2018
Manager Business Development-part-time - StarMedical Equipment, An Ultrasound Company
04.2013 - 09.2015
Facility Manager(part-time) - Sunnybrook Research Institute
10.2003 - 05.2015
R&D Associate/Cellular and Immunochemical Assay Development and Vaccine Stability Expert - Sanofi Pasteur Canada
04.2001 - 03.2022
Genotyping Facility Manager, Immunology Department, University of Toronto - Ontario Cancer Institute (UHN)
01.2000 - 04.2001
Senior Research Associate - Women's College Research Institute
07.1997 - 01.2000
Supervisor/Chief Technologist/Expert Biochemical and Immunochemical Diagnostic Assay Development - Pathobiology Laboratory Center
07.1989 - 03.1997
Ivey Business School University of Western Ontario - Executive Master of Business Administration (EMBA),
University of Toronto - Project Management full Certificate,
Babol (Mazandaran) Medical Sciences University, Iran - Medical Laboratory Sciences BSc. (Major in Immunology) Undergraduate,

Professional And Leadership Training

  • 7 Habit of Highly effective People, Steven R. Covey workshop (2005)
  • Human Relations workshop, Dale Carnegie, (2010)

Volunteer Activities And Other Honors And Awards

  • United Way Campaigner (2003-2019), Sanofi Co-Chair United Way Committee (2003-2004)
  • Awarded Best Teaching Role, Coaching R&D Group, Sanofi Pasteur Canada
  • Ranked 13(among 4000 MLT Graduates), Candidate for Graduate School Iran, 1990
  • Ranked 2, All High School (Grade 12) West Azerbaijan Province, Kurdistan, Iran, 1986

Area Of Expertise

  • A Life dedicated medical laboratory scientist with strong technical background in both diagnostic and research in multiple disciplines; clinical immunology, clinical genetic, clinical chemistry, hematology, pathology, immunohistochemistry, microbiology genetic analysis, vaccine research and development
  • Orderly and analytical critical thinker, expert at identifying opportunities for Improving efficiency, quality, delivery and for earning significant results.
  • Strategic thinker, Business Intelligent, planner, agile and resilient team player
  • Motivated to positively impact the healthcare industry, ultimately patient's lives.
  • Recognized for distinguished mentoring, managing and coaching skills in the clinical, research and development environment.
  • Adaptable, quick, and continuous learner with excellent mind sets to bring positive spirit. improvement programs in complex, highly regulated environments.
  • Determined, Nurturing, committed leader delivering effective programs and curriculum.
  • Natural communicator adept at engaging with stakeholders at all levels.

publication


  • Hakimi J, Azizi A, Ausar S, Todryk S, Rahman N, Brookes R “An adjuvant-modulated vaccine response in human whole blood” Hum Vaccine Immunother. (2018) Hum Vaccine Immunother. 2017 Sep 2;13(9):2130-2134.
  • Hakimi J, Aboutorabian S, To F, Ausar SF, Rahman N, Brookes RH " Screening Vaccine Formulations in Fresh Human Whole Blood. Methods Mol Biol. 2017; 1494:295-304.
  • Aboutorabian S, Hakimi J, Boudet F, Montano S, Dookie A, Roque C, Ausar SF, Rahman N, Brookes RH. A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation. Hum Vaccine Immunother. 2015;11(6):1449-55
  • Brookes RH, Hakimi J, Ha Y, Aboutorabian S, Ausar SF, Hasija M, Smith SG, Todry, Dockrell HM, Rahman N. “Screening vaccine formulations for biological activity using fresh human whole blood.”Hum Vaccin Immunother. 2014;10(4
  • He L, Hakimi J, Salha D, Miron I, Dunn P, Radvanyi L. “A sensitive flow cytometry-based cytotoxic Tlymphocyte assay through detection of cleaved caspase 3 in target cells. J Immunol Methods. 2005 Sep; 304(1-2): 43-59
  • Radvanyi L, Singh-Sandhu D, Gallichan S, Lovitt C, Pedyczak A, Mallo G, Gish K, Kwok K, Hanna W, Zubovits J, Armes J, Venter D, Hakimi J, Shortreed J, Donovan M, Parrington M, Dunn P, Oomen R, Tartaglia J, Berinstein NL. “The gene associated with trichorhinophalangeal syndrome in humans is over expressed in breast cancer ”Proc Natl Acad Sci USA. 2005 Aug 2; 102(31): 11005
  • R. Nam,Y Elhaji, M.Krahn, J.Hakimi, M.Ho, W.Chu, J.Sweet, J.Trachtenberg, M.Jewett Steven.A.Narod “Significance of CAG repeats polymorphism of the androgen receptor gene in prostate cancer progression “The Journal of Urology 2000 Aug; 164: 567-572,
  • G. Kuperstein, W. D Foulkes, P. Ghadirian, J. Hakimi, S.A.Narod“A rapid fluorescent multiplexed –PCR analysis for founder mutations in the BRCA1 and BRCA2 genes “Clin Genet. 2000 Mar 11. R Goshen, W Chu, L Elit, T Pal, J Hakimi, Ackerman I, Fyles A, Mitchell M, Narod SA. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 2000 Dec; 79(3):477-81
  • Eynolahi, J. Keyhani, J. Hakimi, E. Madani, E. Keyhani, “Purification and detection of IgG by Affinity chromatography among systemic lupus erythematous cases” Poster, Second Congress of Blood and related Diseases, Tehran, Iran 1996 12. Jalil Hakimi “Understanding of genetic testing “Journal of American Society of Iranian Medical Professionals Vol.6

Professional And Leadership Training

  • 7 Habit of Highly effective People, Steven R. Covey workshop (2005)
  • Human Relations workshop, Dale Carnegie, (2010)

Volunteer Activities And Other Honors And Awards

  • United Way Campaigner (2003-2019), Sanofi Co-Chair United Way Committee (2003-2004)
  • Awarded Best Teaching Role, Coaching R&D Group, Sanofi Pasteur Canada
  • Ranked 13(among 4000 MLT Graduates), Candidate for Graduate School Iran, 1990
  • Ranked 2, All High School (Grade 12) West Azerbaijan Province, Kurdistan, Iran, 1986

Area Of Expertise

  • A Life dedicated medical laboratory scientist with strong technical background in both diagnostic and research in multiple disciplines; clinical immunology, clinical genetic, clinical chemistry, hematology, pathology, immunohistochemistry, microbiology genetic analysis, vaccine research and development
  • Orderly and analytical critical thinker, expert at identifying opportunities for Improving efficiency, quality, delivery and for earning significant results.
  • Strategic thinker, Business Intelligent, planner, agile and resilient team player
  • Motivated to positively impact the healthcare industry, ultimately patient's lives.
  • Recognized for distinguished mentoring, managing and coaching skills in the clinical, research and development environment.
  • Adaptable, quick, and continuous learner with excellent mind sets to bring positive spirit. improvement programs in complex, highly regulated environments.
  • Determined, Nurturing, committed leader delivering effective programs and curriculum.
  • Natural communicator adept at engaging with stakeholders at all levels.

publication


  • Hakimi J, Azizi A, Ausar S, Todryk S, Rahman N, Brookes R “An adjuvant-modulated vaccine response in human whole blood” Hum Vaccine Immunother. (2018) Hum Vaccine Immunother. 2017 Sep 2;13(9):2130-2134.
  • Hakimi J, Aboutorabian S, To F, Ausar SF, Rahman N, Brookes RH " Screening Vaccine Formulations in Fresh Human Whole Blood. Methods Mol Biol. 2017; 1494:295-304.
  • Aboutorabian S, Hakimi J, Boudet F, Montano S, Dookie A, Roque C, Ausar SF, Rahman N, Brookes RH. A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation. Hum Vaccine Immunother. 2015;11(6):1449-55
  • Brookes RH, Hakimi J, Ha Y, Aboutorabian S, Ausar SF, Hasija M, Smith SG, Todry, Dockrell HM, Rahman N. “Screening vaccine formulations for biological activity using fresh human whole blood.”Hum Vaccin Immunother. 2014;10(4
  • He L, Hakimi J, Salha D, Miron I, Dunn P, Radvanyi L. “A sensitive flow cytometry-based cytotoxic Tlymphocyte assay through detection of cleaved caspase 3 in target cells. J Immunol Methods. 2005 Sep; 304(1-2): 43-59
  • Radvanyi L, Singh-Sandhu D, Gallichan S, Lovitt C, Pedyczak A, Mallo G, Gish K, Kwok K, Hanna W, Zubovits J, Armes J, Venter D, Hakimi J, Shortreed J, Donovan M, Parrington M, Dunn P, Oomen R, Tartaglia J, Berinstein NL. “The gene associated with trichorhinophalangeal syndrome in humans is over expressed in breast cancer ”Proc Natl Acad Sci USA. 2005 Aug 2; 102(31): 11005
  • R. Nam,Y Elhaji, M.Krahn, J.Hakimi, M.Ho, W.Chu, J.Sweet, J.Trachtenberg, M.Jewett Steven.A.Narod “Significance of CAG repeats polymorphism of the androgen receptor gene in prostate cancer progression “The Journal of Urology 2000 Aug; 164: 567-572,
  • G. Kuperstein, W. D Foulkes, P. Ghadirian, J. Hakimi, S.A.Narod“A rapid fluorescent multiplexed –PCR analysis for founder mutations in the BRCA1 and BRCA2 genes “Clin Genet. 2000 Mar 11. R Goshen, W Chu, L Elit, T Pal, J Hakimi, Ackerman I, Fyles A, Mitchell M, Narod SA. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 2000 Dec; 79(3):477-81
  • Eynolahi, J. Keyhani, J. Hakimi, E. Madani, E. Keyhani, “Purification and detection of IgG by Affinity chromatography among systemic lupus erythematous cases” Poster, Second Congress of Blood and related Diseases, Tehran, Iran 1996 12. Jalil Hakimi “Understanding of genetic testing “Journal of American Society of Iranian Medical Professionals Vol.6

Overview

34
34
years of professional experience

Similar Profiles

CREATE PROFILE
Jalil Hakimi PM MBA